The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.
暂无分享,去创建一个
[1] P. Cook. The organization of replication and transcription. , 1999, Science.
[2] B. Wouters,et al. Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin , 1999, British Journal of Cancer.
[3] D A Bloch,et al. Tissue oxygen distribution in head and neck cancer patients , 1999, Head & neck.
[4] S. Spencer,et al. Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a Phase II study. , 1998, International journal of radiation oncology, biology, physics.
[5] C. Langer,et al. Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] G. Semenza. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. , 1998, Current opinion in genetics & development.
[7] M C Weissler,et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. , 1998, Cancer research.
[8] H. Lyng,et al. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. , 1998, British Journal of Cancer.
[9] A. Fyles,et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] D. Chaplin,et al. Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis. , 1998, Seminars in radiation oncology.
[11] P. Glazer,et al. Mutagenesis induced by the tumor microenvironment. , 1998, Mutation research.
[12] J. Brown,et al. Tirapazamine is metabolized to its DNA-damaging radical by intranuclear enzymes. , 1998, Cancer research.
[13] M. Kris,et al. Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] A. Harris,et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[16] B. Wouters,et al. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. , 1997, Radiation research.
[17] P. Glazer,et al. Genetic instability induced by the tumor microenvironment. , 1996, Cancer research.
[18] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[19] P. Hoskin,et al. Microregional blood flow in murine and human tumours assessed using laser Doppler microprobes. , 1996, The British journal of cancer. Supplement.
[20] M. Dewhirst,et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.
[21] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[22] C. Koch,et al. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. , 1995, British Journal of Cancer.
[23] W. Curran,et al. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. , 1995, International journal of radiation oncology, biology, physics.
[24] R. Chin,et al. Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. , 1994, Cancer research.
[25] Durand Re. The influence of microenvironmental factors during cancer therapy. , 1994 .
[26] G L Rosner,et al. Pretreatment oxygenation profiles of human soft tissue sarcomas. , 1994, International journal of radiation oncology, biology, physics.
[27] T. Graeber,et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.
[28] W. Denny,et al. Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771. , 1994, International journal of radiation oncology, biology, physics.
[29] M. Dorie,et al. Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin. , 1993, Cancer research.
[30] J. Brown,et al. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. , 1993, British Journal of Cancer.
[31] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[32] J. Brown,et al. Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation. , 1992, Cancer research.
[33] B. Price,et al. Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. , 1992, Cancer research.
[34] P. Vaupel,et al. Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. , 1991, Cancer research.
[35] R. Mason,et al. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical. , 1991, Molecular pharmacology.
[36] P Vaupel,et al. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.
[37] E. Pettersen,et al. Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia‐induced lethal damage , 1991, Cell proliferation.
[38] A. Koong,et al. Therapeutic advantage of hypoxic cells in tumors: a theoretical study. , 1991, Journal of the National Cancer Institute.
[39] M. Lemmon,et al. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors. , 1990, Cancer research.
[40] T S Herman,et al. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. , 1990, Cancer research.
[41] J. Subjeck,et al. Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. , 1989, Cancer research.
[42] J F Gross,et al. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. , 1989, International journal of radiation oncology, biology, physics.
[43] S. Rockwell,et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. , 1989, International journal of radiation oncology, biology, physics.
[44] P. Olive,et al. Use of a carbocyanine dye as a marker of functional vasculature in murine tumours. , 1989, British Journal of Cancer.
[45] R. Durand. Distribution and activity of antineoplastic drugs in a tumor model. , 1989, Journal of the National Cancer Institute.
[46] C. Grau,et al. Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[47] A. Sartorelli. Therapeutic attack of hypoxic cells of solid tumors: presidential address. , 1988, Cancer research.
[48] Shah-Yukich Aa,et al. Characterization of solid tumor microvasculature: a three-dimensional analysis using the polymer casting technique. , 1988 .
[49] C. Bartels,et al. Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[50] D. Chaplin,et al. Intermittent blood flow in a murine tumor: radiobiological effects. , 1987, Cancer research.
[51] R. Sutherland,et al. Induction characteristics of oxygen regulated proteins. , 1986, International journal of radiation oncology, biology, physics.
[52] D. Chaplin,et al. Acute hypoxia in tumors: implications for modifiers of radiation effects. , 1986, International journal of radiation oncology, biology, physics.
[53] J. Henk. Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitizers? , 1986, International journal of radiation oncology, biology, physics.
[54] P. Fracasso,et al. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells. , 1986, Cancer research.
[55] R. Schimke,et al. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Lemmon,et al. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. , 1986, International journal of radiation oncology, biology, physics.
[57] C. Coleman,et al. Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule. , 1986, International journal of radiation oncology, biology, physics.
[58] T. Grunt,et al. The vascular pattern of basal cell tumors: light microscopy and scanning electron microscopic study on vascular corrosion casts. , 1985, Microvascular research.
[59] S. Dische. Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[60] J. Chapman,et al. The detection and measurement of hypoxic cells in solid tumors , 1984, Cancer.
[61] J. Subjeck,et al. Induction of glucose-regulated proteins during anaerobic exposure and of heat-shock proteins after reoxygenation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[62] J. Brown,et al. Clinical trials of radiosensitizers: what should we expect? , 1984, International journal of radiation oncology, biology, physics.
[63] I. Tannock,et al. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. , 1983, Cancer research.
[64] S. Dische,et al. Carcinoma of the cervix--anaemia, radiotherapy and hyperbaric oxygen. , 1983, The British journal of radiology.
[65] R. Mikkelsen. Extracellular PH and weak acid/weak base drug uptake and cytotoxicity , 1982 .
[66] S. Rockwell,et al. Mitomycin-C as a prototype bioreductive alkylating agent: in vitro studies of metabolism and cytotoxicity. , 1982, International journal of radiation oncology, biology, physics.
[67] D. M. Brown,et al. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use. , 1981, International journal of radiation oncology, biology, physics.
[68] I. Tannock,et al. Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. , 1981, British Journal of Cancer.
[69] J. Brown,et al. Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole. , 1980, Radiation research.
[70] J M Brown,et al. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. , 1979, The British journal of radiology.
[71] R. Sutherland,et al. Resistance to adriamycin in multicellular spheroids. , 1979, International journal of radiation oncology, biology, physics.
[72] R. Hill,et al. Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulated in G2 + M phases after irradiation of a solid tumor in vivo. , 1979, Cancer research.
[73] J. Hendry,et al. Radiobiology for the Radiologist , 1979, British Journal of Cancer.
[74] S. Dische,et al. Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the bladder. , 1978, The British journal of radiology.
[75] A. Rauth,et al. Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells. , 1978, Cancer research.
[76] J. Brown,et al. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo. , 1977, Radiation research.
[77] G. Adams,et al. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. , 1977, British Journal of Cancer.
[78] T. Skovsgaard. Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells. , 1977, Biochemical pharmacology.
[79] A. Sartorelli,et al. Potential Bioreductive Alkylating Agents , 1976 .
[80] A. Rauth,et al. Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells. , 1976, Cancer research.
[81] J. Brown,et al. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582. , 1975, Radiation research.
[82] H. Withers,et al. Enhancement of the radioresponse of a murine tumour by a nitroimidazole , 1975 .
[83] J. Fowler,et al. Radiosensitization of C3H Mouse Mammary Tumours by a 2-Nitroimidazole Drug , 1974, British Journal of Cancer.
[84] P. Sheldon,et al. Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazole. , 1974, The British journal of radiology.
[85] A. Sartorelli,et al. Potential bioreductive alkylating agents. 1. Benzoquinone derivatives. , 1972, Journal of medicinal chemistry.
[86] G. Adams,et al. Radiosensitization of hypoxic cells in vitro: a water-soluble derivative of paranitroacetophenone. , 1972, Nature: New biology.
[87] J. S. Sawyer. Man-made Carbon Dioxide and the “Greenhouse” Effect , 1972, Nature.
[88] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[89] A. F. Phillips,et al. Measurement of Electrode Potentials in Living and Dead Tissues , 1954, Nature.
[90] L. H. Gray,et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.
[91] H. G. Crabtree,et al. The Action of Radium on Cancer Cells. II.--Some Factors Determining the Susceptibility of Cancer Cells to Radium , 1933 .
[92] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[93] S M Bentzen,et al. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. , 1994, Acta oncologica.
[94] J. Overgaard. Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. , 1994, Oncology research.
[95] R. Durand. The influence of microenvironmental factors during cancer therapy. , 1994, In vivo.
[96] S. Rockwell,et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. , 1993, International journal of radiation oncology, biology, physics.
[97] P Vaupel,et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[98] W. Wilson,et al. Tumour hypoxia: challenges for cancer chemotherapy , 1992 .
[99] A. Nias. Radiobiology for the Radiologist (3rd Edition) , 1988 .
[100] A. Nelson,et al. Characterization of solid tumor microvasculature: a three-dimensional analysis using the polymer casting technique. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[101] B. Teicher,et al. The hypoxic tumor cell: a target for selective cancer chemotherapy. , 1980, Biochemical pharmacology.
[102] T. Matsuzawa,et al. Tumor regrowth after irradiation; an experimental approach. , 1979, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[103] G Wiernik,et al. Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix. , 1978, The British journal of radiology.
[104] R. Willson,et al. Radiosensitization of anoxic cells by metronidazole. , 1973, The British journal of radiology.
[105] M. Ozima,et al. Excess Argon in Submarine Basalts and an Earth-Atmosphere Evolution Model , 1972 .
[106] G. Adams,et al. Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria. , 1969, International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine.